CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Y. Linhares, C. Freytes, M. Cherry, C. Bachier, Michael Maris, D. Hoda, J. Varela, Courtney Bellomo, Scott Cross, J. Essell, S. Fanning, H. Terebelo, H. Yimer, Jay Courtright, J. Sharman, A. Kostić, M. Vedal, K. Ogasawara, A. Avilion, R. Espinola, Brenda Yuan, B. Mattar
{"title":"CT-045 Primary Results From OUTREACH: A Phase II Study of Lisocabtagene Maraleucel (Liso-Cel) Administered in the Community Setting as Outpatient or Inpatient Treatment in Patients With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)","authors":"Y. Linhares, C. Freytes, M. Cherry, C. Bachier, Michael Maris, D. Hoda, J. Varela, Courtney Bellomo, Scott Cross, J. Essell, S. Fanning, H. Terebelo, H. Yimer, Jay Courtright, J. Sharman, A. Kostić, M. Vedal, K. Ogasawara, A. Avilion, R. Espinola, Brenda Yuan, B. Mattar","doi":"10.1016/s2152-2650(23)01482-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)01482-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
